SCHEMBL24083533

SCHEMBL24083533

COC1C(O[C@H]2OC(CO[C@H]3OC(C(=O)O)[C@@H](O)C(O)C3O)[C@@H](O)C(O)[C@@H]2O)[C@H](I)OC(C)[C@@H]1O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ F10 P00742 5/20 0.39
▸ CD209 Q9NNX6 2/20 0.35
▸ BDNF P23560 2/20 0.35
▸ PTN P21246 1/20 0.35
▸ MDK P21741 1/20 0.35
▸ FGF2 P09038 1/20 0.35
▸ PRKCA P17252 1/20 0.34
▸ FGF1 P05230 1/20 0.34
▸ STAT3 P40763 3/20 0.34
▸ AMY2A P04746 2/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ ALOX15 P16050 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ MMP2 P08253 1/20 0.33
▸ MMP3 P08254 1/20 0.33
▸ MMP9 P14780 1/20 0.33
▸ MMP12 P39900 1/20 0.33
▸ MMP13 P45452 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19018816 1.00 F10 (0.39) F10CD209BDNFPTNMDK
SCHEMBL19027025 1.00 F10 (0.39) F10CD209BDNFPTNMDK
SCHEMBL19026619 0.93 F10 (0.37) F10CD209BDNFPTNMDK
SCHEMBL21233365 0.90 F10 (0.41) F10CD209BDNFPTNMDK
SCHEMBL21233245 0.90 F10 (0.41) F10CD209BDNFPTNMDK
SCHEMBL22778359 0.90 F10 (0.41) F10CD209BDNFPTNMDK
SCHEMBL22778350 0.90 F10 (0.41) F10CD209BDNFPTNMDK
SCHEMBL24080164 0.90 F10 (0.41) F10CD209BDNFPTNMDK
SCHEMBL19773367 0.90 F10 (0.41) F10CD209BDNFPTNMDK
SCHEMBL19773431 0.90 F10 (0.41) F10CD209BDNFPTNMDK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3919076-A1 SYNTHETIC OLIGOSACCHARIDE VACCINES AGAINST STREPTOCOCCUS PNEUMONIAE WITH MICROPARTICLE ADJUVANT FORMULATIONS Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2021-12-08 — — EP disclosed
Send feedback